[DOI] [PMC free article] [PubMed] [Google Scholar] Gariani K, Menzies KJ, Ryu D, Wegner CJ, Wang X, Ropelle ER, et al
In the summer of 2023, the second phase involved participatory observation, further interviews, and a social media analysis
Es una herramienta de aritmtica RUO, no una recomendacin de uso
Retatrutide is strictly intended for use by: Qualified scientific researchers Laboratory personnel Healthcare professionals involved in metabolic research It is important to emphasise that retatrutide is classified as a research chemical
Poster Session II - ACUTE ISCHEMIC STROKE MANAGEMENT 01.00 - ACUTE ISCHEMIC STROKE MANAGEMENT - 01.04 - THROMBOLYSIS P622 - ESOC25-554 A MULTICENTER, PROSPECTIVE, RANDOMIZED, OPEN-LABEL, BLINDED-ENDPOINT TRIAL OF TENECTEPLASE FOR ACUTE NON-LARGE VESSEL OCCLUSION IN EXTENDED TIME WINDOW (OPTION): RATIONALE AND DESIGN Ran Mo 1 , Gaoting MA 1 , Junwei Hao 1 1 Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China Background and Aims: Intravenous thrombolysis, the standard of care for acute ischemic stroke (AIS) within 4.5 hours of symptom onset, is generally not offered to patients presenting beyond this time window